X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2609) 2609
science & technology (2365) 2365
life sciences & biomedicine (2185) 2185
proto-oncogene proteins b-raf - antagonists & inhibitors (1621) 1621
proto-oncogene proteins b-raf - genetics (1515) 1515
oncology (1266) 1266
mutation (1094) 1094
melanoma - drug therapy (964) 964
animals (942) 942
cell line, tumor (866) 866
melanoma (862) 862
female (803) 803
proto-oncogene proteins b-raf - metabolism (687) 687
melanoma - genetics (679) 679
male (672) 672
protein kinase inhibitors - pharmacology (641) 641
melanoma - pathology (618) 618
mice (591) 591
antineoplastic agents - therapeutic use (537) 537
protein kinase inhibitors - therapeutic use (505) 505
cancer (493) 493
middle aged (473) 473
antineoplastic agents - pharmacology (461) 461
cell biology (459) 459
aged (390) 390
skin neoplasms - drug therapy (380) 380
signal transduction (368) 368
adult (348) 348
kinases (336) 336
cell proliferation - drug effects (335) 335
signal transduction - drug effects (318) 318
biochemistry & molecular biology (315) 315
sulfonamides - pharmacology (315) 315
braf (314) 314
melanoma - metabolism (310) 310
sulfonamides - therapeutic use (310) 310
indoles - pharmacology (302) 302
research (299) 299
care and treatment (295) 295
indoles - therapeutic use (294) 294
skin neoplasms - pathology (291) 291
molecular targeted therapy (286) 286
metastasis (281) 281
tumors (276) 276
apoptosis (272) 272
vemurafenib (271) 271
dermatology (266) 266
apoptosis - drug effects (265) 265
map kinase signaling system - drug effects (264) 264
treatment outcome (262) 262
xenograft model antitumor assays (262) 262
neoplasms (257) 257
genetic aspects (256) 256
skin neoplasms - genetics (256) 256
phosphorylation (238) 238
proteins (235) 235
antineoplastic combined chemotherapy protocols - therapeutic use (233) 233
drug resistance, neoplasm (232) 232
pharmacology & pharmacy (226) 226
drug resistance, neoplasm - genetics (218) 218
colorectal neoplasms - genetics (212) 212
melanoma - enzymology (209) 209
analysis (208) 208
health aspects (201) 201
colorectal neoplasms - drug therapy (198) 198
gene mutations (198) 198
ras proteins - genetics (197) 197
proto-oncogene proteins - genetics (196) 196
proto-oncogene proteins c-akt - metabolism (195) 195
mitogen-activated protein kinase kinases - antagonists & inhibitors (187) 187
colorectal cancer (186) 186
receptor, epidermal growth factor - antagonists & inhibitors (183) 183
aged, 80 and over (182) 182
science & technology - other topics (180) 180
extracellular signal-regulated map kinases - metabolism (179) 179
multidisciplinary sciences (177) 177
cell proliferation (173) 173
mice, nude (172) 172
neoplasm metastasis (171) 171
gene expression (170) 170
prognosis (168) 168
neoplasms - drug therapy (166) 166
mutation - genetics (161) 161
antineoplastic agents - adverse effects (160) 160
drug resistance, neoplasm - drug effects (159) 159
melanoma - secondary (159) 159
protein kinase inhibitors - adverse effects (159) 159
colorectal neoplasms - pathology (158) 158
protein kinase inhibitors - administration & dosage (157) 157
sulfonamides - adverse effects (156) 156
antibodies, monoclonal - therapeutic use (155) 155
indoles - adverse effects (154) 154
drug resistance (153) 153
immunotherapy (152) 152
gene expression regulation, neoplastic (151) 151
proto-oncogene proteins p21 (151) 151
drug therapy (143) 143
chemotherapy (142) 142
disease-free survival (140) 140
phosphatidylinositol 3-kinases - metabolism (140) 140
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2773) 2773
French (30) 30
German (18) 18
Japanese (11) 11
Czech (5) 5
Russian (5) 5
Hungarian (4) 4
Chinese (3) 3
Spanish (2) 2
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Polish (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 02/2008, Volume 105, Issue 8, pp. 3041 - 3046
Journal Article
Nature (London), ISSN 1476-4687, 11/2010, Volume 468, Issue 7326, pp. 973 - 977
Journal Article
Nature (London), ISSN 1476-4687, 11/2010, Volume 468, Issue 7326, pp. 968 - 972
...(1). Pre-clinical studies have demonstrated that the B-RAF(V600E) mutation predicts a dependency on the mitogen-activated protein kinase (MAPK... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Allosteric Regulation | Humans | Gene Expression Regulation, Neoplastic | Melanoma - enzymology | Gene Expression Profiling | MAP Kinase Signaling System | Mitogen-Activated Protein Kinase Kinases - metabolism | Melanoma - genetics | Indoles - pharmacology | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Gene Library | Proto-Oncogene Proteins c-raf - genetics | MAP Kinase Kinase Kinases - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Proto-Oncogene Proteins - genetics | Clinical Trials as Topic | MAP Kinase Kinase Kinases - metabolism | Enzyme Activation - drug effects | Open Reading Frames - genetics | Sulfonamides - pharmacology | Proto-Oncogene Proteins c-raf - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Drug Resistance, Neoplasm - genetics | Sulfonamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Indoles - therapeutic use | Protein Kinase Inhibitors - pharmacology | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinases - metabolism | Protein research | Research | Properties | Protein kinases | Cancer cells | Cell lines | Biochemistry | Mutation | Kinases | Genes | Cancer
Journal Article
Nature (London), ISSN 1476-4687, 02/2010, Volume 464, Issue 7287, pp. 427 - 430
Tumours with mutant BRAF are dependent on the RAF–MEK–ERK signalling pathway for their growth. We found that ATP-competitive RAF inhibitors inhibit ERK... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neoplasms - metabolism | ras Proteins - genetics | Phosphorylation | raf Kinases - antagonists & inhibitors | Humans | Protein Multimerization | Transcriptional Activation - drug effects | ras Proteins - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | raf Kinases - metabolism | Mitogen-Activated Protein Kinase Kinases - metabolism | Neoplasms - genetics | Adenosine Triphosphate - metabolism | Indoles - pharmacology | raf Kinases - genetics | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Cell Line | raf Kinases - chemistry | Catalytic Domain | Neoplasms - enzymology | Enzyme Activation - drug effects | Sulfonamides - pharmacology | Neoplasms - drug therapy | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Animals | MAP Kinase Signaling System - drug effects | Models, Biological | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Cell Line, Tumor | Protein Binding | Mice | Protein Kinase Inhibitors - pharmacology | Protein Kinase Inhibitors - metabolism | Care and treatment | Enzyme inhibitors | Gene mutations | Cellular signal transduction | Genetic aspects | Research | Health aspects | Cancer | Proteins | Competition | Drugs | Mutation | Kinases | Tumors | Index Medicus
Journal Article
Nature (London), ISSN 1476-4687, 11/2011, Volume 480, Issue 7377, pp. 387 - 390
Journal Article
Journal Article